Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Enrico Cortesi

Showing results (111-120 of 174) with videos related to

Pageof 18
Sort By:
BMC Cancer|November 16, 2004
Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phageEmiliano Pavoni, Paola Vaccaro, Andrea Pucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumabAndrea Sartore-Bianchi, Mauro Moroni, Silvio Veronese, et al.
Biomedicines|May 16, 2023
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a ChallengeMiriam Tomaciello, Miriam Conte, Francesca Romana Montinaro, et al.
Anticancer Research|August 5, 2006
Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve casesNello Salesi, Roberto Pistilli, Vincenzo Marcelli, et al.
European Urology|September 12, 2012
Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY)Sergio Bracarda, Camillo Porta, Corrado Boni, et al.
Breast Cancer Research and Treatment|July 19, 2006
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer familiesGiuseppe Giannini, Carlo Capalbo, Elisabetta Ristori, et al.
European Journal of Human Genetics : EJHG|November 17, 2005
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC softwareCarlo Capalbo, Enrico Ricevuto, Annarita Vestri, et al.
Clinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.
The Lancet. Oncology|August 13, 2010
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trialGianluca Masi, Fotios Loupakis, Lisa Salvatore, et al.
Cancers|September 23, 2022
Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients-A Retrospective Observational StudyStefania Brozzetti, Chiara D'Alterio, Simone Bini, et al.
Pageof 18

Showing results (111-120 of 174) with videos related to

Sort By:
Pageof 18
BMC Cancer|November 16, 2004
Identification of a panel of tumor-associated antigens from breast carcinoma cell lines, solid tumors and testis cDNA libraries displayed on lambda phageEmiliano Pavoni, Paola Vaccaro, Andrea Pucci, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 1, 2007
Epidermal growth factor receptor gene copy number and clinical outcome of metastatic colorectal cancer treated with panitumumabAndrea Sartore-Bianchi, Mauro Moroni, Silvio Veronese, et al.
Biomedicines|May 16, 2023
Abscopal Effect on Bone Metastases from Solid Tumors: A Systematic Review and Retrospective Analysis of Challenge within a ChallengeMiriam Tomaciello, Miriam Conte, Francesca Romana Montinaro, et al.
Anticancer Research|August 5, 2006
Bisphosphonates and oral cavity avascular bone necrosis: a review of twelve casesNello Salesi, Roberto Pistilli, Vincenzo Marcelli, et al.
European Urology|September 12, 2012
Could interferon still play a role in metastatic renal cell carcinoma? A randomized study of two schedules of sorafenib plus interferon-alpha 2a (RAPSODY)Sergio Bracarda, Camillo Porta, Corrado Boni, et al.
Breast Cancer Research and Treatment|July 19, 2006
Novel BRCA1 and BRCA2 germline mutations and assessment of mutation spectrum and prevalence in Italian breast and/or ovarian cancer familiesGiuseppe Giannini, Carlo Capalbo, Elisabetta Ristori, et al.
European Journal of Human Genetics : EJHG|November 17, 2005
Improving the accuracy of BRCA1/2 mutation prediction: validation of the novel country-customized IC softwareCarlo Capalbo, Enrico Ricevuto, Annarita Vestri, et al.
Clinical Colorectal Cancer|September 10, 2011
Outcome of second-line treatment after first-line chemotherapy with the GONO FOLFOXIRI regimenLorenzo Fornaro, Enrico Vasile, Gianluca Masi, et al.
The Lancet. Oncology|August 13, 2010
Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trialGianluca Masi, Fotios Loupakis, Lisa Salvatore, et al.
Cancers|September 23, 2022
Surgical Resection Is Superior to TACE in the Treatment of HCC in a Well Selected Cohort of BCLC-B Elderly Patients-A Retrospective Observational StudyStefania Brozzetti, Chiara D'Alterio, Simone Bini, et al.
Pageof 18